Iron Absorption in Haiti

NCT ID: NCT02096250

Last Updated: 2015-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-30

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The government of Haiti plans to introduce a flour fortification program. The aim of the project it to inform the authorities on the most suitable iron compound for this fortification program. For this purpose, iron absorption from wheat flour using different iron compounds will be investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NaFeEDTA

NaFeEDTA

Group Type EXPERIMENTAL

NaFeEDTA

Intervention Type OTHER

Ferrous fumarate

Ferrous fumarate

Group Type EXPERIMENTAL

Ferrous fumarate

Intervention Type OTHER

NaFeEDTA + ferrous fumarate

NaFeEDTA + ferrous fumarate

Group Type EXPERIMENTAL

NaFeEDTA + ferrous fumarate

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NaFeEDTA

Intervention Type OTHER

Ferrous fumarate

Intervention Type OTHER

NaFeEDTA + ferrous fumarate

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women of reproductive age (18 to 45 years)
* Generally healthy
* Consenting to study participation


* Age 4 years +/- 12 months
* Generally healthy

Exclusion Criteria

* Pregnancy or lactation
* Weight \>65 kg
* Chronic illnesses which may influence iron absorption
* Severe anemia (Hb\<10 g/dl)


* Severe anemia (Hb\<10 g/dl)
* Weight for height \< -2 Z scores (wasting)
* Height of age \< -2 Z score (stunting)


* Chronic illnesses or medication which may influence iron absorption (will be judged by investigator)
* Consumption of vitamin or mineral supplement (unless they agree to discontinue using them two weeks before beginning of the study until the las visit)
* Allergies or intolerances relevant to the test meal (gluten)
* Blood donation or major blood losses during the 2 months prior to the study
* Illness during the 4 weeks prior to the study (will be judged by investigator)
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Atomic Energy Agency

OTHER_GOV

Sponsor Role collaborator

Swiss Federal Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Isabelle Aeberli

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Isabelle Aeberli, PhD

Role: PRINCIPAL_INVESTIGATOR

ETH Zurich (Switzerland)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ministère de la Santé Publique et de la Population

Port-au-Prince, , Haiti

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Haiti

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK 2013-N43

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Iron-fortified Whole Maize Flour Trial
NCT00386074 COMPLETED PHASE2